Inventor · disambiguated record
Bryce A. Harrison
Also filed as: HARRISON BRYCE A · HARRISON BRYCE ALDEN
33 granted patents·9 pending applications·130 citations·filing 2003–2024
97Inventor score
Files withMORPHIC THERAPEUTIC INC19LEXICON PHARMACEUTICALS INC8FORUM PHARMACEUTICALS INC4HARRISON BRYCE ALDEN3BURGOON HUGH ALFRED2
Top patents by PatentIndex Score
42 records- 0196US12145935B2Inhibitors of (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2023·Granted Nov 19, 2024·4 cites·20 claims
- 0296US11795167B2Inhibitors of (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2021·Granted Oct 24, 2023·5 cites·19 claims
- 0395US11827621B2Inhibitors of (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2021·Granted Nov 28, 2023·5 cites·9 claims
- 0495US11021480B2Inhibiting (α-V)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2020·Granted Jun 1, 2021·8 cites·2 claims
- 0594US12415796B2Inhibitors of (αv)(β6) integrinMORPHIC THERAPEUTIC INC·Filed 2023·Granted Sep 16, 2025·2 cites·8 claims
- 0694US11739087B2Inhibiting (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2021·Granted Aug 29, 2023·5 cites·9 claims
- 0794US11046669B2Inhibitors of (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2019·Granted Jun 29, 2021·8 cites·35 claims
- 0893US11046685B2Inhibitors of (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2018·Granted Jun 29, 2021·8 cites·42 claims
- 0993US11040955B2Inhibitors of (alpha-v)(beta-6) integrinMORPHIC THERAPEUTIC INC·Filed 2018·Granted Jun 22, 2021·8 cites·59 claims
- 1093US10759756B2Antagonists of human integrin α4β7MORPHIC THERAPEUTIC INC·Filed 2019·Granted Sep 1, 2020·7 cites·42 claims
- 1193US7781577B2Inhibitors of sodium glucose co-transporter 2 and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2007·Granted Aug 24, 2010·18 cites·27 claims
- 1291US7846945B2Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2008·Granted Dec 7, 2010·10 cites·33 claims
- 1389US11370773B1Inhibiting human integrin (alpha-4) (beta-7)MORPHIC THERAPEUTIC INC·Filed 2021·Granted Jun 28, 2022·2 cites·24 claims
- 1487US10106569B2Inhibitors of sodium glucose transporter 1 for constipationLEXICON PHARMACEUTICALS INC·Filed 2017·Granted Oct 23, 2018·5 cites·1 claims
- 1587US9688710B2Inhibitors of sodium glucose cotransporter 1LEXICON PHARMACEUTICALS INC·Filed 2015·Granted Jun 27, 2017·5 cites·8 claims
- 1686US8026347B2Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitorsLEXICON PHARMACEUTICALS INC·Filed 2008·Granted Sep 27, 2011·9 cites·42 claims
- 1785US12459942B2Inhibiting (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2024·Granted Nov 4, 2025·0 cites·18 claims
- 1885US12221416B2Antagonists of human integrin α4β7MORPHIC THERAPEUTIC INC·Filed 2023·Granted Feb 11, 2025·0 cites·20 claims
- 1985US9200025B2Inhibitors of sodium glucose cotransporter 1LEXICON PHARMACEUTICALS INC·Filed 2013·Granted Dec 1, 2015·7 cites·15 claims
- 2084US2025223289A1Inhibitors of (alpha-v)(beta-6) integrinMORPHIC THERAPEUTIC INC·Filed 2024·Application pending·0 cites
- 2183US11174228B2Antagonists of human integrin (α4)(β7)MORPHIC THERAPEUTIC INC·Filed 2020·Granted Nov 16, 2021·1 cites·20 claims
- 2281US11104661B1Inhibiting human integrin (α-4) (β-7)MORPHIC THERAPEUTIC INC·Filed 2020·Granted Aug 31, 2021·1 cites·24 claims
- 2381US8476413B2Sulfanyl-tetrahydropyran-based compounds and methods of their useHARRISON BRYCE ALDEN·Filed 2010·Granted Jul 2, 2013·4 cites·31 claims
- 2473US8507672B2Substituted pyrrolo[2,3-d]pyrimidines as LIM kinase 2 inhibitorsHARRISON BRYCE ALDEN·Filed 2008·Granted Aug 13, 2013·2 cites·12 claims
- 2573US8193202B2LIMK2 inhibitors, compositions comprising them, and methods of their useBURGOON HUGH ALFRED·Filed 2009·Granted Jun 5, 2012·2 cites·7 claims
- 2672US9365602B2Sodium glucose co-transporter inhibitors and methods of their useHARRISON BRYCE ALDEN·Filed 2013·Granted Jun 14, 2016·1 cites·1 claims
- 2772US2022340529A1Antagonists of human integrin (alpha4)(beta7)MORPHIC THERAPEUTIC INC·Filed 2021·Application pending·0 cites
- 2869US8293878B2Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitorsGOODWIN NICOLE CATHLEEN·Filed 2011·Granted Oct 23, 2012·2 cites·14 claims
- 2968US2020071322A1Inhibiting (alpha-v)(beta-6) integrinMORPHIC THERAPEUTIC INC·Filed 2019·Application pending·0 cites
- 3067US2020354359A1Inhibiting (alpha-v)(beta-6) integrinMORPHIC THERAPEUTIC INC·Filed 2020·Application pending·0 cites
- 3166US8450332B2LIMK2 inhibitors, compositions comprising them, and methods of their useBURGOON HUGH ALFRED·Filed 2012·Granted May 28, 2013·1 cites·7 claims
- 3262US2019099436A1Sodium glucose co-transporter inhibitors and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3357US2017087172A1Sodium glucose co-transporter inhibitors and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3451US2023219949A1Inhibitors of (alpha-v)(beta-6) integrinHARRISON BRYCE A·Filed 2022·Application pending·0 cites
- 3545US7223888B2Mu opioid receptor ligands: methods of use and synthesisHARVARD COLLEGE·Filed 2003·Granted May 29, 2007·0 cites·37 claims
- 3644US9802927B2Oxadiazine compounds and methods of use thereofDENALI THERAPEUTICS INC·Filed 2016·Granted Oct 31, 2017·0 cites·19 claims
- 3744US7759514B2Mu opioid receptor ligands: methods of use and synthesisHARRISON BRYCE A·Filed 2007·Granted Jul 20, 2010·0 cites·31 claims
- 3839US10370370B2Aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptorsFORUM PHARMACEUTICALS INC·Filed 2016·Granted Aug 6, 2019·0 cites·13 claims
- 3938US10428062B2Geminal substituted aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptorsFORUM PHARMACEUTICALS INC·Filed 2016·Granted Oct 1, 2019·0 cites·13 claims
- 4038US2017050980A1Oxadiazine compounds and methods of use thereofFORUM PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4137US2017247393A1Aminoisoxazoline Compounds as Agonists of Alpha7-Nicotinic Acetylcholine ReceptorsFORUM PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4235US10183938B2Geminal substituted quinuclidine amide compounds as agonists of α-7 nicotonic acetylcholine receptorsAXOVANT SCIENCES GMBH·Filed 2015·Granted Jan 22, 2019·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Bryce A. Harrison files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →